Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
Kitamura S, Lin TH, Lee CD, Takamura A, Kadam RU, Zhang D, Zhu X, Dada L, Nagai E, Yu W, Yao Y, Sharpless KB, Wilson IA, Wolan DW.
Kitamura S, et al.
Proc Natl Acad Sci U S A. 2024 May 28;121(22):e2310677121. doi: 10.1073/pnas.2310677121. Epub 2024 May 16.
Proc Natl Acad Sci U S A. 2024.
PMID: 38753503